PharmiWeb.com - Global Pharma News & Resources

Company Directory

PharmiWeb's Pharma Company Directory is a comprehensive and searchable listing of organisations within the Pharma, Biotech & Life Sciences sector. Use it to find partner organisations, suppliers, or even a company to work for!

As an organisation, a basic listing is FREE, and can raise your profile in the industry, making you visible to thousands of monthly site visitors.

To add your organisation to the directory, simply register as a contributor and add your organisation's details. You can also upgrade to a premium listing - this offers even greater scope for added content (more photos, more links, more copy), and even more exposure. For more information, use our enquiry form here.

Note that we only accept contributions relating to the Pharma industry and that it will typically take 2 working days to approve (or otherwise) your details. Once approved, you will also be able to contribute press releases and event details to our site.

Create a free account to list your company for free!

Accellacare is a global clinical research network increasing patient recruitment and retention with a patient centric approach. Accellacare extends across the globe with 82 active research sites in six countries with expertise in a wide range of therapeutic areas. It has relationships with 275 Principal Investigators connecting it to 8 million+ patients.
Accelsiors delivers strategic solutions for conducting global clinical trials with the ultimate objective of improving public health. We dedicate ourselves to serving the needs of our customers with talented and motivated staff, a commitment to quality, global regulatory experience and expertise and a personal touch.
We're more than a consulting and talent solutions business. We are passionate about providing our clients and candidates with the most effective talent and consulting partnership available in the Life Sciences market. Accenian innovates to stay ahead of our competition so that you can stay ahead of yours.
Our mission is to join the hospitals, pharmacists, wholesalers, and other front-line healthcare providers in the vital delivery of life-sustaining drugs to their patients. We place orders with the highest levels of precision, take personal and mutual responsibility for support needs, and consider the patient's well-being as our primary goal.
Ace Therapeutics is a preclinical contract research provider. Ace Therapeutics has a group of highly skilled researchers with the objective of providing innovative preclinical contract research solutions to cope with various types of diseases.
Acella Pharmaceuticals, LLC is a specialty pharmaceutical company committed to innovating the healthcare field by bringing quality and affordable products to our customers and patients. Our diverse portfolio of therapeutic products helps patients with a variety of healthcare needs.
ACHIEVA comprises five respected specialist recruitment businesses*1, joining forces to become one stronger and more powerful entity, bolstered by research, development and environmental enterprises that share our core values.
Achilles Therapeutics is a biopharmaceutical company developing personalised T cell therapies targeting neoantigens: protein markers unique to each individual that are present on the surface of a cancer cell and can be detected by the immune system.
As a Swiss pharmaceutical company headquartered in Zurich, we develop, manufacture and internationally market well-proven and innovative pharmaceuticals in novel drug delivery forms. We are a leader in advanced drug delivery technologies with a focus on modified release oral forms, and oral dispersible forms, for which we also hold patents.
We are focused on leveraging core expertise in drug discovery and development and kinase inhibition to develop novel, small molecule therapies to help people impacted by under served immuno-inflammatory conditions. Our team of experienced and accomplished kinome experts use the proprietary KINect® technology platform to generate clinical candidates for difficult to drug kinases with novel approaches.
We are focused on bringing innovation to the treatment of cachexia with a vision to transform care for an under-served and vulnerable patient population, prolong and improve the quality of their lives, restore their dignity and ease the burden for the patient, carer and provider.
We are at a breakthrough moment for Alzheimer’s disease research and drug development. At Acumen, we are leveraging decades of learnings to deliver treatments that can truly impact everyone affected by this devastating disease.